1.
Kasurinen A, Laitinen A, Kokkola A, Stenman U-H, Böckelman C, Haglund C. Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer. AO [Internet]. 2020 Jun. 2 [cited 2026 May 16];59(6):681-8. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24220